LEO Pharma has appointed Beth-Anne Lang, Vice President and Head of Global Regulatory Affairs and Christine Garrett, Vice President and Head of Global Project Management, within the Global Development Team.
Ms Lang has broad regulatory experience in early and late development across several therapeutic areas and in biologics. She will be tasked with leading and transforming the regulatory into an even more modern and global organization. Ms Garrett is tasked with leading a new program management organisation to strengthen LEO’s global drug development capabilities and help make innovation available to patients faster.
“LEO Pharma appoints Global Regulatory Affairs and Global Project Management VPs“
Christian Antoni, Head of Development, LEO Pharma, said: “LEO Pharma is building the world’s best dermatology R&D organisation, nothing less. The appointment of Beth-Anne Lang and Christine Garrett is a key milestone in achieving this ambition. Beth-Anne and Christine’s vast experience with global leadership roles in multi-country cross functional teams and diverse portfolios combined with their strong technical and scientific backgrounds will be critical in our constant quest for improving science to the benefit of patients.”